title: Diabetes: novel therapeutic developments. 21-22 September 1999, London, UK.
abstract: The treatment of diabetes represents an extremely active area of new product development. The goal is to effectively regulate glucose in a physiological manner, so as to reduce HbA1c levels and the complications of diabetes. An extremely broad range of new products for the treatment of Type I and/or Type II diabetes are in the pipeline. These include: new forms and methods of delivering insulin to increase compliance; novel pharmaceutical agents to reduce serum glucose and HbA1c levels; immunoregulatory agents which will prevent or reverse diabetic autoimmunity; glucose sensor-insulin pump feedback loops; and, transplantation of xenogeneic islets in immunoprotected microreactors.
authors.affiliation: BioHybrid Technologies Inc, Park Nine West, Shrewsbury, MA 01545, USA. stiwolf@aol.com
authors.forename: D E
authors.initials: DE
authors.lastname: Wolf